Nasal administration of agents for the treatment of gastroparesis
US6770262B2 · kind B2 · utility
10Cited by
6References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2001 |
| Grant date | Aug 3, 2004 |
| Priority date | — |
| Expiry date | Mar 29, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a method for the treatment of gastroparesis by the use of metoclopramide nasal formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.